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Abstract
Background: While dealing with mixed in vitro lymphocyte cultures one is faced with the problem
of relative contributions of different populations to the activity being studied. This is especially true
in the controversy relating to the contributions of lymphocyte sub-populations to the Lymphokine
Activated Killer (LAK) phenomenon. Flowcytometry can be used to highlight relative contributions
of lymphocyte subpopulations towards LAK activity without resorting to difficult purification
strategies. We set up long-term in vitro lymphocyte cultures, stimulated them with cytokines IL-2/
IL-12, recorded their phenotypic changes and cytotoxic activity against U-937 tumor targets.
Results:  The results indicated that natural killer cells (NK) constituted the predominant
proliferating cell population in the cytokine stimulatedcultures. Flowcytometric evidence revealed
that CD56+ T cells contributed little to LAK activity against U937 target cells as compared to cells
with NK phenotype which were predominantly responsible for spontaneous killing of the tumor
targets. The two cytokines, IL-2 and IL-12, had an additive effect on cell proliferation and
spontaneous cytotoxicity.
Conclusion: Flowcytometry can be used to rapidly delineate phenotypic changes in immune cells
after stimulation and simultaneously correlate them with corresponding functional activity. This
approach may find application as a initial screening tool for studying different types of cells in mixed
cultures and their respective activities under stimulatory / inhibitory conditions.
Background
The  in vitro culture of human peripheral blood lym-
phocytes in IL-2 results in the generation of cytotoxic cells
that lyse tumor targets. Natural Killer (NK) cells are the
main lymphocytic population constitutively expressing
p75β chain of the IL-2 receptor and exhibiting up-regula-
tion of LFA-1 (Lymphocyte Function associated Antigen-
1) molecule upon IL-2 stimulation. Consequently, incu-
bation of peripheral blood lymphocytes with IL-2 induces
selective activation of NK cells, rapid increase of NK activ-
ity followed by generation of LAK activity and prolifera-
tion. This has been referred to as the LAK
phenomenon[1]. Similarly IL-12 treatment of peripheral
blood mononuclear cells (PBMC) or pure NK cells within
a few hours, induces, an enhancement of cytotoxic ability.
It was observed that the maximum enhancement ob-
tained with IL-12 is less than that obtained with IL-2 and
comparable to that observed with IFN-γ. However, IL-12
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was found to be effective at concentrations 2–3 order of
magnitude lower than IL-2/IFN-γ. Maximum enhance-
ment of NK mediated cytotoxicity was observed with a
combination of IL-12 and IL-2, the effect of the two cy-
tokines together being additive[2]. Another study revealed
that cytokine stimulated NK cells use both granzyme/Fas
ligand pathways of apoptotic induction to mediate cyto-
toxicity[3] and it was found that IL-2 and IL-12 both in-
crease induction in mRNA coding for perforin/ granzymes
A and B[4]. Hence the importance of both these cytokines
in enhancing cytotoxicity cannot be overlooked.
However before this picture about the involvement of NK
cells in LAK activity emerged there existed considerable
controversy regarding the type of effector cells mediating
this activity, particularly concerning the relative contribu-
tions by the two lymphocyte populations, NK Vs cytotoxic
T cells [5–9]. Experiments in which, depletion of Asialo-
GM (a glycolipid present on the surface of NK cells) was
carried out, demonstrated, that the generation of LAK cells
followed by IL-2 stimulation was considerably reduced,
thereby confirming that the NK cells are the major con-
tributors of LAK activity[10]. Further, studies with sorted
pure populations of CD3/NK cells also showed that the
LAK phenomenon is predominantly mediated by IL-2 ac-
tivated NK cells. Both precursor and effector cells of this
activity were typically NK cells[11]. Direct evidence that
NK cells are the mediators of LAK activity came from Im-
munotransmission Electron microscopic studies using
colloidal gold labeled antibodies in which CD16 positive
cells were shown to extend their protrusions deep into the
target cells and it was found that the cytoplasmic granules
and vacuoles of CD16 positive LAK cells were concentrat-
ed in the area of the binding site[12]. With the advent of
flowcytometry and immunophenotyping we thought we
could approach this dilemma in a different but simple
and straightforward manner. Therefore we generated LAK
cells by the method of Anita and Hersh[13] and carried
out cytotoxicity experiments with the stimulated cells. For
our cytotoxicity experiments we used the U-937 cell line
which are derived from human histiocytic lymphoma as
tumor targets. U937 cells share many surface markers and
receptors with normal human monocytes and therefore
express many monocyte like characteristics [14–17]. Con-
currently we also assessed the changes in the phenotypic
characteristics by flowcytometry. Flowcytometry is a pow-
erful tool that allows one to study not only freshly isolated
lymphocytes but also cells that have been cultured in Vitro
and allowed to proliferate in the presence of stimulating
factors. This helps to qualitatively as well as quantitatively
assess the phenotypic nature of the proliferating cells in
Vitro. In the present study our aim was to find out the rel-
ative contributions of cells of different phenotypes to
spontaneous cytotoxicity and study the effect of long term
in vitro stimulation of cytokines on mixed lymphocyte cul-
tures.
Results
A study was undertaken to see the effect of IL-2 and/or IL-
12 stimulation on a long term basis and correlate the phe-
notypic changes of the proliferating population corre-
sponding to their cytotoxic abilities after in vitro culture of
the peripheral blood lymphocytes. LAK cells were generat-
ed as described. At regular time points the cells were har-
vested. The chromium release cytotoxic assay was
performed by the standard procedure and compared with
the corresponding phenotypic characteristics of the cells,
by flowcytometry. A dot plot was generated to gate for the
cells after stimulation. A representative dot plot of unstim-
ulated and stimulated cells is shown in Figure 1.
In the Figures 2 to 7, the line graph represents percentage
51Cr release values indicating the percentage NK cytotox-
icity at different time points in response to different stim-
uli. The bar diagrams indicate the corresponding
phenotypic characteristics of the cells as assessed by flow-
Figure 1
Representative scatter plot of basal and stimulated
lymphocytes by flowcytometry : The gate G1 in figure 1a
represents the basal lymphocytes while gate G2 in figure 1b
represents cells after in vitro stimulation with cytokines.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/9
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cytometry. The total cells were analysed after appropriate-
ly applying the gate on the corresponding dot plots.
It can be seen that IL-2 at 50 U/106 cells is very effective in
inducing proliferation of NK cells & simultaneously aug-
menting cytotoxicity (Figure 3). The percentage of NK
cells (blue bar) rises from a basal value of 12 ± 3 % of the
total lymphocytes on day zero to 50 ± 5 % of the total
lymphocytes on day 14. Simultaneously percentage cyto-
toxicity (line graph) also rises from a basal value of 12.7 ±
4.2 % on day zero to 86 ± 7.1 % on day 14 concurring
with the increase in NK cells. When IL-2 at a concentration
of 50 U/106 cells was added along with IL-12 at a concen-
tration of 125 U/106 cells, there was an increase of NK
phenotype up to 47 ± 5.2 % on day 11 and a correspond-
ing maximum NK activity of 91 ± 6.5 % (Figure 5). Equal-
ly impressive augmentation of NK activity was seen even
at lower concentrations of IL-2 and IL-12 in combination.
At IL-2 concentration of 5 U/106 cells along with IL-12
concentration of 25 U/106 cells, there was an increase of
NK phenotype up to 35 ± 3.1 % on day 9 and a corre-
sponding maximum NK activity of 60 ± 9.4 % (Figure 4).
But when IL-2 alone was added at the same low concen-
tration, percentage of NK cells is only 9.4 ± 2.2 % on day
7 corresponding to maximum NK activity of only 35 ± 3.9
% (Figure 2). However IL-12 by itself at concentrations of
25 U or 125 U/106 cells is unable to cause neither an in-
crease in the NK phenotype nor in their cytotoxic ability
(Figure 6 &7).
From Figures 2,3,4,5,6,7 it is evident that initially on day
2 even though there is a transient increase in the CD56+ve
T cells (green bars) up to 25–45% the corresponding in-
crease in the chromium release values against U937 target
cells is negligible even at a high dose of IL-2. In contrast,
at later time points when the cytotoxicity goes up to 86–
91%, there are very few CD56+ T cells as compared to the
NK cell phenotype. The proportion of T cells (red bars)
also has no bearing on the NK activity.
Discussion
Following low dose IL-2 treatment in leprosy patients, NK
cell numbers were found to increase 6-fold and IL-2 ther-
apy of HIV patients resulted in enhanced NK and LAK cell
activity in vitro[18] IL-2 subcutaneously given resulted in,
in vivo expansion of CD16 positive NK cells to very large
numbers which showed LAK activity and ADCC (Anti-
body Dependent Cellular Cytotoxicity) in vitro[19]. In
view of the above mentioned and other reports available
in literature, a pilot study was undertaken to see the effect
of IL-2 and/or IL-12 stimulation on a long term basis and
study the phenotypic changes corresponding to the cyto-
toxic changes after in vitro culture of the peripheral blood
lymphocytes.
The results obtained from these long term stimulation
studies have thrown up interesting points for debate. The
phenotypic analysis of the PBMC cultured in the presence
of IL-2 and/or IL-12 from 0 to 14 days has brought to light
that there is a gradual increase in the percentage of NK
cells suggesting that these cells constitute the predomi-
Figure 2
Stimulation with IL-2 (5 U/106 cells): The line and bar
graphs indicate the NK activity and the phenotypic character-
istics respectively after in vitro stimulation with IL-2 for 0–14
days. The blue filled bar represents NK cells, the red bar rep-
resents T cells and the green bar represents the CD56 posi-
tive T cells. Results are expressed as Mean ± SD (n = 3).
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Figure 3
Stimulation with IL-2 (50 U/106 cells): The line and bar
graphs indicate the NK activity and the phenotypic character-
istics respectively after in vitro stimulation with IL-2 for 0–14
days. The blue filled bar represents NK cells, the red bar rep-
resents T cells and the green bar represents the CD56 posi-
tive T cells. Results are expressed as Mean ± SD (n = 3).
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FIGURE 3BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/9
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nant cell population in these cultures. This observation is
consistent with the results of others where they have
shown an increase up to 73% of NK cells on day 9 in re-
sponse to IL-2 and IL-12 [20]. Even at low concentrations
when IL-2 is added along with IL-12, it is able to cause
substantial increase in NK cell proliferation and activity
(Figure 4) comparable to the effect seen when IL-2 is add-
ed alone at higher concentrations (Figure 3). Hence the
two cytokines together appear to have an additive effect as
reported by other workers [21].
The most striking observation from our experiments is
that it provides clear evidence that the "CD56+ T cells"
contribute little to cytotoxic activity against the U937 tar-
get cell line. It is seen from the figures 2,3,4,5,6,7, that
when NK cell number increases, the NK activity also in-
creases. Initially on day 2 even though there is a transient
increase in the CD56+ T cell population a corresponding
increase in the chromium release values is not observed at
a low dose of IL-2 (figure 2) and only a very marginal in-
crease is seen at a higher dose of IL-2 (figure 3) although
the CD56 positive T cells are more than double the basal
level. In contrast, at later time points when the cytotoxici-
ty goes up to 86–91%, there are very few CD56 positive T
cells as compared to the NK cell phenotype reaffirming
that it is the NK phenotype that is mostly responsible for
the spontaneous killing of U-937 tumor targets. Similar studies have been carried out using other tumor targets
such as K562, COLO, WILMS, MELANOMA and P815.
Some researchers have reported the ability of CD56 posi-
tive T cells to exhibit spontaneous killing against some of
the targets such as K562 or P815, upon stimulation with
IL-2 [22–25]. However Lanier and Philips who carried out
extensive studies on the LAK phenomenon have empha-
sised that although CD16+ T cells exhibit non-MHC-re-
stricted cytotoxicity to some targets upon IL-2
stimulation, their contribution was quantitatively and
qualitatively very minimal as compared to the NK sub-
set[7,11]. The differences in the ability of lymphocytes of
different phenotypes to respond to IL-2 stimulation and
carry out spontaneous lysis of different targets could prob-
ably be attributed to the differential expression of inhibi-
tory receptors present on the targets such as KIR and
CD94:NKG2 [26].
Another important observation is that IL-12 by itself at
concentrations of 25 U or 125 U/106 cells is unable to
cause neither an increase in the Natural Killer phenotype
nor in their cytotoxic ability (Figure 6 &7). This is in agree-
ment with the reported literature where it has been report-
ed that IL-12 can act only on pre-stimulated cells and has
little or no effect on resting lymphocytes[27]. IL-12 is a cy-
tokine produced to some degree by B lymphocytes but
mostly by phagocytic cells including monocytes, macro-
phages, neutrophils, epidermal cells, keratinocytes and
dendritic cells which are among the first cells to encounter
Figure 4
Stimulation with IL-2+IL-12 (5 U + 50 U/106 cells):
The line and bar graphs indicate the NK activity and the phe-
notypic characteristics respectively after in vitro stimulation
with IL-2 and IL-12 for 0–14 days. The blue filled bar repre-
sents NK cells, the red bar represents T cells and the green
bar represents the CD56 positive T cells. Results are
expressed as Mean ± SD (n = 3).
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FIGURE 4
Figure 5
Stimulation with IL-2+IL-12 (50 U + 125 U/106 cells):
The line and bar graphs indicate the NK activity and the phe-
notypic characteristics respectively after in vitro stimulation
with IL-2 and IL-12 for 0–14 days. The blue filled bar repre-
sents NK cells, the red bar represents T cells and the green
bar represents the CD56 positive T cells. Results are
expressed as Mean ± SD (n = 3).
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FIGURE 5BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/9
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a foreign antigen during infection in response to bacteria,
bacterial products, intracellular parasites, etc [2]. It was
found that IL-12 induced directional migration of highly
enriched preparations of NK cells and CD3 activated cells
but not resting T cells and monocytes. When NK cells were
treated overnight with IL-12 they showed augmented
binding to epithelial cells (EC) by the LFA /ICAM path-
ways. Thus by inducing migration and interaction with
EC, IL-12 regulates crucial determinants of NK cell recruit-
ment in tissues[20]. It is believed that IL-12 plays an in-
strumental role in tilting the immune response in favor of
T helper type 1 by generation of Th1 cells and consequent-
ly initiates CMI[28]. Since IL-12 enhances cytotoxicity and
augments proliferation by antigen specific T cells and NK
cells, IL-12 may facilitate antigen specific and nonspecific
cytotoxic immune defense against intracellular pathogens
such as M. tuberculosis. An intriguing property of IL-12 is
its capacity to induce proliferation by cytolytic T cell only
upon co-stimulation with antigen. IL-12 may thus be a
candidate to control the cytolytic arm of initial immune
response to pathogens by inducing expansion of cytotoxic
T cell only when antigen is encountered [29]. The biologic
significance of the multiplicity of cytokines which can
stimulate the proliferation of T and NK cells is unclear. It
may be that the various lymphokine growth factors are
differentially produced at different time points during the
ontogeny of the immune system at different stages in the
development of an immune response or at different sites
within the body or lymphoid tissues [30]. Our studies
have confirmed the importance of multiple cytokine stim-
ulation of lymphocytes and how NK cells are crucial to the
development of spontaneous cytotoxicity and are the ma-
jor contributors to LAK activity in vitro when U-937 cells
were used as targets. The use of flowcytometry to under-
stand the in vitro effects of cytokine stimulation makes
one's task easier as studies can be carried out on mixed
lymphocyte populations.
Conclusions
The use of flowcytometry as a tool in correlating the func-
tional capacity of various subpopulations of mixed lym-
phocyte cultures to their phenotype has been
demonstrated. A study was undertaken to correlate the
phenotypic changes corresponding to the cytotoxic poten-
tial of human peripheral blood lymphocytes after long
term in vitro stimulation with IL-2 and IL-12 cytokines. As
reported in literature flowcytometric evidence also point-
ed to the fact that double positive cells constituting the cy-
totoxic T cells contribute little to Lymphokine Activated
Killer activity, reaffirming that in a mixed lymphocyte cul-
ture it is the NK phenotype that is responsible for the
spontaneous killing of tumor targets. Thus flowcytometry
can be easily applied to situations where one needs to
quickly understand the phenotypic changes with respect
to their corresponding functional capacity in response to
various stimulants or inhibitory agents even on mixed
cells populations.
Figure 6
Stimulation with IL-12 (50 U/106 cells): The line and bar
graphs indicate the NK activity and the phenotypic character-
istics respectively after in vitro stimulation with IL-12 for 0–14
days. The blue filled bar represents NK cells, the red bar rep-
resents T cells and the green bar represents the CD56 posi-
tive T cells. Results are expressed as Mean ± SD (n = 3).
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Figure 7
Stimulation with IL-12 (125 U/106 cells): The line and
bar graphs indicate the NK activity and the phenotypic char-
acteristics respectively after in vitro stimulation with IL-12 for
0–14 days. The blue filled bar represents NK cells, the red
bar represents T cells and the green bar represents the
CD56 positive T cells. Results are expressed as Mean ± SD
(n = 3).
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Materials and Methods
Media and reagents
RPMI 1640 culture medium was supplemented with 5%
heat inactivated FCS, 2 mM glutamine, 5 mM HEPES, 5 ×
10-5 M 2-ME, 100 U/ml penicillin, 20 µg/ml gentamycin
(pH 7.2–7.4) (Complete medium). Ficoll hypaque,
RPMI-1640 and all other culture reagents were purchased
from Sigma Chemical Co., St. Louis, U.S.A. 51Chromium
was obtained from BARC, Mumbai, India. Monoclonal
antibodies were purchased from Becton and Dickinson,
San Jose, CA. Some of the monoclonal antibodies were a
kind gift from NIH, Bethesda, U.S.A. U937, tumor target
cell-line was obtained from National facility for animal
tissue and cell culture, DBT, Govt., of India, Pune, India.
rIL-2 cytokine was purchased from Genezyme, USA and
rIL-12 cytokine was a kind gift from Trinchieri G, Philadel-
phia, USA. All plastic ware were obtained from Costar,
Cambridge, MA and Falcon, NJ, USA.
Preparation of human mononuclear cells (PBMC)
Blood was collected from 3 normal, healthy volunteers in
heparinised containers. It was gently layered over equal
quantities of Ficoll-Hypaque density gradient and centri-
fuged at 1800 rpm for 30 min. PBMC from the interface
were washed twice in Hank's Balanced Salt Solution by
centrifugation at 1500 rpm for 15 min. The washed PBMC
were suspended in complete RPMI medium and adjusted
to a volume of 10 × 106 cells/ml.
Long term stimulation studies
2.5 × 106 PBMCs were cultured in a total volume of 500
µl complete medium in 48-well tissue culture plates in the
presence of (1) IL-2 (5 U/106 cells), (2) IL-2 (50 U/106
cells), (3) IL-2+IL-12 (5 U+25 U/106 cells), (4) IL-2+IL-12
(50 U+125 U/10 6 cells), (5) IL-12 (25 U/106 cells) and
(6) IL-12 (125 U/106 cells). The cells were harvested and
washed on days 2, 4, 7, 9, 11 & 14. Chromium release as-
say was performed and samples were also analyzed by
flowcytometer at all time points including day 0 (fresh PB-
MC).
Phenotyping for flowcytometry
0.25 × 106 cells/250 µl medium were added to three tubes
and 5 µl of isotype control, leucogate and monoclonal an-
tibody anti-CD3PE + CD16/CD56 FITC conjugate was
added to the respective tubes. The tubes were incubated
for 15 min at 4°C in dark and washed with cold PBS at
1200 rpm for 5 min. The stained cells were fixed with 0.5
ml 1% paraformaldehyde and kept (covered with foil) at
4°C until further analysis on Flowcytometer (Becton and
Dickinson, San Jose, CA) using Cell Quest software.
Statistical analysis
Statistical analysis (mean, standard deviation and graph-
ics) was performed with Microsoft Excel.
51Chromium release assay
1 × 106 target U937 cells in 100 µl medium were labeled
with 100 µci 51Cr in a sterile screw-capped 4 ml falcon
tube & incubated for 1 hr at 37°C in a CO2 incubator. Tar-
get cells were then washed twice by centrifugation at 1200
rpm for 10 min and suspended in complete medium at a
concentration of 0.1 million cells/ml. 0.01 × 106 radio-la-
beled target cells in 100 µl were mixed with 0.5 × 106 lym-
phocytes in 50 µl to give an E:T ratio of 50:1 in triplicates
in a U-bottom 96-well tissue culture plate. Total volume
was made up with complete medium and adjusted to 250
µl/well. Control wells containing only target cells were
also processed simultaneously. For spontaneous cytotox-
icity, one set of triplicates was set up in which volume was
adjusted to 250 µl with medium alone. In another set, 100
µl of 1% Triton X and 150 µl medium was added and this
was considered as maximum lysis. The 96-well plate was
centrifuged at slow speed (1000 rpm) for 2–5 min to ena-
ble contact between effectors and targets. Incubation was
carried out for 4 h at 37°C in a humidified CO2 incubator.
Plates were then centrifuged & 150 µl supernatant was
carefully removed and transferred to a plastic vial. Counts
were recorded in a Gamma counter and percentage cyto-
toxicity was calculated as follows:
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